Stay updated on Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0; the page still shows a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T03:00:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-27T06:24:12.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-20T06:28:32.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-13T08:00:09.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study content with an error screen. This indicates that access to the study record is blocked.
    Difference
    18%
    Check dated 2026-09-22T03:24:27.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page now displays an updated revision tag (v3.6.6) replacing the previous version (v3.6.5). This indicates a minor revision to the page metadata.
    Difference
    0.1%
    Check dated 2026-08-31T23:16:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Muscle-invasive Bladder Cancer Clinical Trial page.